TTKHLTCARE

TTK Healthcare Share Price

₹1,537.70 -1.1 (-0.07%)

05 Nov, 2024 17:15

SIP TrendupStart SIP in TTKHLTCARE

Start SIP

Performance

  • Low
  • ₹1,520
  • High
  • ₹1,543
  • 52 Week Low
  • ₹1,245
  • 52 Week High
  • ₹1,894
  • Open Price₹1,531
  • Previous Close₹1,539
  • Volume1,981

Investment Returns

  • Over 1 Month -4.58%
  • Over 3 Month -6.02%
  • Over 6 Month + 1.45%
  • Over 1 Year + 22.23%
SIP Lightning

Smart Investing Starts Here Start SIP with TTK Healthcare for Steady Growth!

TTK Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.2
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 2,173
  • P/B Ratio
  • 2.2
  • Average True Range
  • 49.01
  • EPS
  • 44.5
  • Dividend Yield
  • 0.7
  • MACD Signal
  • -27.5
  • RSI
  • 38.24
  • MFI
  • 21.44

TTK Healthcare Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations198.49207.90181.06183.85185.77
Total Income From Operations198.49207.90181.06183.85185.77
P/L Before Interest, Excpt. Items & Tax23.9321.8825.1617.9322.29
P/L Before Exceptional Items & Tax23.1921.0224.2317.7021.56
P/L After Tax from Ordinary Activities17.2031.5818.2712.8916.01
Net Profit/Loss For the Period17.2031.5818.2712.8916.01
IndicatorMar 24Mar 23
Revenue From Operations [Gross]747.64720.19
Revenue From Operations [Net]747.64720.19
Total Operating Revenues752.79725.11
Total Revenue815.40773.44
Total Expenses731.28711.81
Profit/Loss Before Tax84.1261.64
Profit/Loss For The Period62.84639.71
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-4.94-26.08
Net Cash Used In Investing Activity28.4932.96
Net Cash Used in Finance Activity-21.91-12.43
Net Inc/Dec In Cash And Equivalent1.64-5.54
Cash And Equivalent End Of Year10.969.32
IndicatorMar 24Mar 23
Total Share Capital14.1314.13
Total Non-Current Liabilities3.865.95
Total Current Liabilities195.82210.78
Total Capital And Liabilities1,200.591,170.11
Total Non-Current Assets123.30104.04
Total Current Assets1,077.301,066.07
Total Assets1,200.591,170.11
Indicator20242023
EBIT Margin (%)11.549.22
Return On Capital Employed (%)8.646.97
Return On Equity (%)6.3067.41
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)705.23671.59
Indicator20242023
EBIT Margin (%)11.549.22
Return On Capital Employed (%)8.646.97
Return On Equity (%)6.3067.41
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)705.23671.59

TTK Healthcare Technicals

EMA & SMA

Current Price
₹1,537.70
-1.1 (-0.07%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹1,583.34
  • 50 Day
  • ₹1,607.77
  • 100 Day
  • ₹1,586.81
  • 200 Day
  • ₹1,523.20

Resistance and Support

1539.12 Pivot Speed
  • R3 1,613.73
  • R2 1,588.97
  • R1 1,563.88
  • S1 1,514.03
  • S2 1,489.27
  • S3 1,464.18

Is TTK Healthcare Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

TTK Healthcare Ltd. operates across diverse sectors, offering pharmaceuticals, medical devices, consumer products, and animal care solutions. With a strong presence in India, it provides trusted healthcare and wellness products that cater to both domestic and global markets. T T K Healthcare (Nse) has an operating revenue of Rs. 771.29 Cr. on a trailing 12-month basis. An annual revenue growth of 5% is not great, Pre-tax margin of 11% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -14% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 92 which is a GREAT score indicating consistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

TTK Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-25 Quarterly Results
2024-08-02 Quarterly Results
2024-05-24 Audited Results & Final Dividend
2024-02-02 Quarterly Results
2023-11-03 Quarterly Results

TTK Healthcare F&O

TTK Healthcare Shareholding Pattern

74.56%
0%
1.9%
0.01%
16.02%
7.51%
  • NSE Symbol
  • TTKHLTCARE
  • BSE Symbol
  • 507747
  • ISIN
  • INE910C01018

TTK Healthcare FAQs

TTK Healthcare share price is ₹1,537 As on 05 November, 2024 | 17:01

The Market Cap of TTK Healthcare is ₹2172.8 Cr As on 05 November, 2024 | 17:01

The P/E ratio of TTK Healthcare is 27.2 As on 05 November, 2024 | 17:01

The PB ratio of TTK Healthcare is 2.2 As on 05 November, 2024 | 17:01

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form